Alligator Bioscience AB (STU:7AL) Total Liabilities : €12.25 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Alligator Bioscience AB Total Liabilities?

Alligator Bioscience AB's Total Liabilities for the quarter that ended in Mar. 2024 was €12.25 Mil.

Alligator Bioscience AB's quarterly Total Liabilities increased from Sep. 2023 (€8.64 Mil) to Dec. 2023 (€9.53 Mil) and increased from Dec. 2023 (€9.53 Mil) to Mar. 2024 (€12.25 Mil).

Alligator Bioscience AB's annual Total Liabilities increased from Dec. 2021 (€4.96 Mil) to Dec. 2022 (€7.33 Mil) and increased from Dec. 2022 (€7.33 Mil) to Dec. 2023 (€9.53 Mil).

Alligator Bioscience AB Total Liabilities Historical Data

The historical data trend for Alligator Bioscience AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alligator Bioscience AB Total Liabilities Chart

Alligator Bioscience AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

5.02

3.61

4.96

7.33

9.53

Alligator Bioscience AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															8.52	8.75	8.64	9.53	12.25

Alligator Bioscience AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Alligator Bioscience AB's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	8.857	+	(0.672	+	5.5511151231258E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	9.53

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	10.589	-	1.06
	=	9.53

Alligator Bioscience AB's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	11.777	+	(0.476	+	8.8817841970013E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	12.25

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	7.756	-	-4.497
	=	12.25

Alligator Bioscience AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Alligator Bioscience AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Alligator Bioscience AB (STU:7AL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alligator Bioscience AB (STU:7AL) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

ATORX:Sweden 7AL:Germany

Address

Scheelevagen 2, Medicon Village, Lund, SWE, 223 81

Website

http://www.alligatorbioscience.com

Alligator Bioscience AB is a research-based biotechnology company that develops immune activating antibody drugs for tumor-directed immunotherapy. It is engaged in the development of immunotherapies for the treatment of cancer Its products are ADC-1013, ATOR-1015, and ATOR-1016.

Alligator Bioscience AB (STU:7AL) Headlines

No Headlines